These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 33247657

  • 1. Pre-Basal Insulin Analog Era: Paving the Way for Modern Day Basal Insulins.
    Tiwaskar M, Deb P, Khadgawat R, Sreenivasamurthy L, Deka N, Karthik B, Karuppan A, Bhattacharjee D, Mohan V.
    J Assoc Physicians India; 2020 Dec; 68(12[Special]):9-12. PubMed ID: 33247657
    [Abstract] [Full Text] [Related]

  • 2. Gla-100 Development: a Story of 'Serendipitous' Disruptive Innovation.
    Badgandi M, Negalur V, Reddy PS, Venkataraman S, Kota S, Barman KK, Jayaprassad V, Pasha MY, Sruthisri P, Mohan V.
    J Assoc Physicians India; 2020 Dec; 68(12[Special]):13-17. PubMed ID: 33247658
    [Abstract] [Full Text] [Related]

  • 3. Insulin preparations with prolonged effect.
    Owens DR.
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S5-14. PubMed ID: 21668337
    [Abstract] [Full Text] [Related]

  • 4. Insulin glargine: long-acting basal insulin analog for improved metabolic control.
    Gerich JE.
    Curr Med Res Opin; 2004 Jan; 20(1):31-7. PubMed ID: 14741069
    [Abstract] [Full Text] [Related]

  • 5. The past, present, and future of basal insulins.
    Pettus J, Santos Cavaiola T, Tamborlane WV, Edelman S.
    Diabetes Metab Res Rev; 2016 Sep; 32(6):478-96. PubMed ID: 26509843
    [Abstract] [Full Text] [Related]

  • 6. Intermediate-acting insulin preparations: NPH and lente.
    Deckert T.
    Diabetes Care; 1980 Sep; 3(5):623-6. PubMed ID: 7192205
    [Abstract] [Full Text] [Related]

  • 7. Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus.
    Chatterjee S, Tringham JR, Davies MJ.
    Expert Opin Pharmacother; 2006 Jul; 7(10):1357-71. PubMed ID: 16805721
    [Abstract] [Full Text] [Related]

  • 8. Treatment persistence in the use of basal insulins in Poland and Germany
.
    Rathmann W, Czech M, Franek E, Kostev K.
    Int J Clin Pharmacol Ther; 2017 Feb; 55(2):119-125. PubMed ID: 27879196
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?
    Bell DS.
    Drugs; 2007 Feb; 67(13):1813-27. PubMed ID: 17722952
    [Abstract] [Full Text] [Related]

  • 11. Degludec: a novel basal insulin.
    Kalra S, Baruah MP, Niazi AK.
    Recent Pat Endocr Metab Immune Drug Discov; 2012 Jan; 6(1):18-23. PubMed ID: 22280221
    [Abstract] [Full Text] [Related]

  • 12. Insulin analogues: new dimension of management of diabetes mellitus.
    Siddiqui NI.
    Mymensingh Med J; 2007 Jan; 16(1):117-21. PubMed ID: 17344794
    [Abstract] [Full Text] [Related]

  • 13. A review of basal insulins.
    Barnett AH.
    Diabet Med; 2003 Nov; 20(11):873-85. PubMed ID: 14632712
    [Abstract] [Full Text] [Related]

  • 14. Novel insulins: expanding options in diabetes management.
    Gerich JE.
    Am J Med; 2002 Sep; 113(4):308-16. PubMed ID: 12361817
    [Abstract] [Full Text] [Related]

  • 15. Long-Acting Basal Insulins: A Review of the More Recently Approved Agents.
    Gallegos Aragon K, Elmaoued AA, Pham NT, Conklin JR, Ray GM.
    Cardiol Rev; 2019 Sep; 27(5):260-266. PubMed ID: 31393288
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.
    Duckworth W, Davis SN.
    J Diabetes Complications; 2007 Sep; 21(3):196-204. PubMed ID: 17493554
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.